Although KMT2C and ANKRD11 mutations were more prevalent in the GBC with PBM cohort than in the reference cohort, with odds ratios of 3.588 and 5.427, respectively, the differences did not reach statistical significance (Figure S1 a).
← all excerpts
Molecular insights into HER2/ERBB2 amplification and carcinogenesis in gallbladder cancer associated with pancreaticobiliary maljunction.
1
—
—